| SHARP published: Ezetimibe/simvastatin reduces risk of atherosclerotic events ... - TheHeart.Org |
|
|
TheHeart.Org The results, first presented at the American Society of Nephrology Renal Week 2010 in Denver, CO, and reported by heartwire at that time, highlight a benefit of lipid-lowering in patients with CKD, despite negative primary-end-point results from two |